Literature DB >> 2649675

Autoimmunity in Graves' ophthalmopathy: a review.

A P Weetman1.   

Abstract

Entities:  

Mesh:

Year:  1989        PMID: 2649675      PMCID: PMC1292041          DOI: 10.1177/014107688908200313

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  54 in total

1.  Prevalence and clinical associations of intraocular pressure changes in Graves' disease.

Authors:  C Allen; D Stetz; S H Roman; S Podos; P Som; T F Davies
Journal:  J Clin Endocrinol Metab       Date:  1985-07       Impact factor: 5.958

2.  Involvement of endogenous gabaergic system in the modulation of gonadotropin secretion in normal cycling women.

Authors:  G B Melis; V Mais; A M Paoletti; F Beneventi; F D Petacchi; P Fioretti
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

3.  Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence.

Authors:  M Schumacher; S Camp; Y Maulet; M Newton; K MacPhee-Quigley; S S Taylor; T Friedmann; P Taylor
Journal:  Nature       Date:  1986 Jan 30-Feb 5       Impact factor: 49.962

4.  Failure to detect eye muscle membrane specific autoantibodies in Graves' ophthalmopathy.

Authors:  H Sikorska; J R Wall
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-31

5.  Type beta transforming growth factor: a bifunctional regulator of cellular growth.

Authors:  A B Roberts; M A Anzano; L M Wakefield; N S Roche; D F Stern; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  Evaluation of endocrine ophthalmopathy with saccadic eye movements.

Authors:  L Mauri; O Meienberg; E Roth; M P König
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

7.  Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.

Authors:  T Kuroki; J Ruf; L Whelan; A Miller; J R Wall
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

8.  Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.

Authors:  C M Rotella; R Zonefrati; R Toccafondi; W A Valente; L D Kohn
Journal:  J Clin Endocrinol Metab       Date:  1986-02       Impact factor: 5.958

9.  Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.

Authors:  P W Wang; Y Hiromatsu; E Laryea; L Wosu; J How; J R Wall
Journal:  J Clin Endocrinol Metab       Date:  1986-08       Impact factor: 5.958

10.  Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy.

Authors:  M Faryna; J Nauman; A Gardas
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19
View more
  3 in total

1.  The use of low voltage electric therapy in the treatment of 'Graves ophthalmopathy'.

Authors:  O Fakhri
Journal:  Int Ophthalmol       Date:  1991-05       Impact factor: 2.031

Review 2.  Radiotherapy for Graves' disease. The possible role of low-dose radiotherapy.

Authors:  Meritxell Arenas; Sebastià Sabater; Pedro Lara Jiménez; Àngels Rovirosa; Albert Biete; Victoria Linares; Montse Belles; Julià Panés
Journal:  Rep Pract Oncol Radiother       Date:  2016-03-04

3.  Inferior oblique muscle biopsy in Graves' ophthalmopathy.

Authors:  T U Hoogenraad; K E Tan
Journal:  J R Soc Med       Date:  1989-09       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.